Drug and Alcohol HIT News
Treatment for opioid dependence has an important role in suicide prevention
Opioid agonist treatment, commonly methadone or buprenorphine, for people dependent on heroin or other opioid…
Bristol Health Partners conference puts lived experience at heart of health research
Bristol Health Partners held its annual Conference on Tuesday 12 October 2021. Like last year,…
Tobacco and alcohol may increase likelihood of using illegal drugs, new study shows
The use of legal drugs (tobacco and alcohol) may lead to the use of cannabis,…
Challenging the stigma of opioid substitution treatment at Drug and Alcohol HIT workshop
Bristol Health Partners’ Drug and Alcohol Health Integration Team (HIT) brought together people from…
Drug and Alcohol HIT meeting focuses on trauma informed approaches
The Drug and Alcohol HIT network met virtually on 30 June 2021. Chair Dr Julian…
Drug and Alcohol HIT looks back at 2020-21
Our Drug and Alcohol HIT co-directors Leonie Roberts, Kyla Thomas, Tim Williams and Jo…
Opioid agonist treatment could substantially reduce drug related deaths if used more widely
Opioid agonist treatment could substantially reduce drug related deaths if used more widely New…
Public consultation on Bristol's new Drug and Alcohol Strategy now open
A new strategy is being developed to support people with drug and alcohol dependency in…
HIT Conference goes virtual to address the impact of COVID-19 and wider health inequalities
Bristol Health Partners held its annual Health Integration Team (HIT) Conference as an entirely…
Former Bristol Health Partners intern Megan Davies reflects on her unconventional journey into academia
Megan completed an internship with Bristol Health Partners in 2018 and has since grown…
Drug and Alcohol HIT look back on 2019-20
Directors of the Drug and Alcohol Health Integration Team (HIT) Dr Kyla…
